Abbott Norvir Capsule Production Problem Leaves Liquid As Only Formulation
Executive Summary
Abbott's protease inhibitor Norvir (ritonavir) soon will be available only in liquid form as the company works to correct a manufacturing problem resulting in improper dissolution of the capsule form, the company said in a letter to doctors, pharmacists and patients.
You may also be interested in...
Abbott Norvir Returns To Market Via Contract Manufacturer
Abbott's HIV protease inhibitor Norvir capsules will be available the week of July 5 as a soft gelatin reformulation outsourced to a contract manufacturer.
Abbott Norvir Returns To Market Via Contract Manufacturer
Abbott's HIV protease inhibitor Norvir capsules will be available the week of July 5 as a soft gelatin reformulation outsourced to a contract manufacturer.
Norvir
Abbott files NDA for soft-gel capsule formulation of the protease inhibitor ritonavir. Manufacture of the original capsules was stopped because a new crystalline structure encountered during production affected the product's dissolution (1"The Pink Sheet" Aug. 3, 1998, p. 21). The product "was reformulated to accommodate a new and stable crystalline structure of ritonavir." Oral solution continues to be available in the interim